C. Caeiro

发表

Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas

M. Honavar, R. Reis, M. Rosner, 2012, PloS one.

Recurrent Ovarian Cancer with BRCAness Phenotype: A Treatment Challenge

C. Caeiro, T. André, I. Leão, 2022, Advances in Therapy.

Hypertension and proteinuria as clinical biomarkers of response to bevacizumab in glioblastoma patients

C. Caeiro, R. Vaz, P. Linhares, 2020, Journal of Neuro-Oncology.

Current Standards of Care in Glioblastoma Therapy

C. Caeiro, Catarina Fernandes, A Costa, 2017 .

Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study.

M. Honavar, R. Reis, F. Pardal, 2010, Oncology reports.

Venous Thromboembolism and Intracranial Hemorrhage in Patients with High-grade Glioma

C. Caeiro, Andreia Costa, C. Sarmento, 2019, Annals of Oncology.

Second-Line Chemotherapy in Recurrent Glioblastoma: A 2-Cohort Study

C. Caeiro, M. Damasceno, L. Castro, 2015, Oncology Research and Treatment.

The Role of Cyclin-Dependent Kinase 4/6 Inhibitors Treatment in Oligometastatic Breast Cancer: A Case Report on a Possible Curative Intent Strategy

C. Caeiro, I. Augusto, A. Valente, 2023, Cureus.

Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option

C. Caeiro, M. Ribeiro, Catarina Fernandes, 2022, Case Reports in Oncology.

Impact of Drug-Drug Interaction between CDK4/6 Inhibitors and Proton Pump Inhibitors on Survival Outcomes in the Treatment of Metastatic Breast Cancer—Real World Data from a Portuguese Center

C. Caeiro, A. Valente, Catarina Fernandes, 2022, Journal of Cancer Therapy.